Skip to content

13F-HR filed by EcoR1 Capital, LLC

EcoR1 Capital, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 30 holding rows worth $888,086,000.

Accession
0001140361-18-007942
Filed
2018-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 31 entries on the cover page, a total value of $888,086,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $888,086,000 with VALUE read as thousands by filing date, 13F file number 028-16764. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ASSEMBLY BIOSCIENCES INC045396108COM2,943,164$133,178,000thousands by filing date
FIBROGEN INC31572Q808COM2,047,737$97,063,000thousands by filing date
CELGENE CORP151020904COM875,000$91,315,000thousands by filing datecall
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK5,885,583$88,225,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR2,107,600$84,430,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock3,766,852$57,633,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM4,836,547$43,674,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock2,882,712$36,899,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock936,163$32,859,000thousands by filing date
MYOKARDIA INC62857M105COM778,393$32,770,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM1,144,558$24,837,000thousands by filing date
SPARK THERAPEUTICS INC84652J903CALL455,500$23,422,000thousands by filing datecall
MACROGENICS INC556099109COM1,140,794$21,675,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM530,161$15,406,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock3,562,600$13,894,000thousands by filing date
ATYR PHARMA INC002120103COM3,917,972$13,713,000thousands by filing date
FIBROGEN INC31572Q908CALL285,400$13,528,000thousands by filing datecall
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR110,384$10,350,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR83,667$8,176,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X908COM CL A500,000$7,495,000thousands by filing datecall
CORVUS PHARMACEUTICALS INC221015100COM588,432$6,096,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM1,840,725$5,301,000thousands by filing date
UNIQURE NVN90064901CALL263,900$5,170,000thousands by filing datecall
KINDRED BIOSCIENCES INC COM494577109Stock544,880$5,149,000thousands by filing date
CLEMENTIA PHARMACEUTICALS IN185575107COM194,166$3,685,000thousands by filing date
MADRIGAL PHARMACEUTICALS INC COM558868105Stock35,000$3,213,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock200,000$3,128,000thousands by filing date
XENCOR INC98401F105COMMON STOCK112,976$2,476,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM103,240$1,884,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J905COM75,000$1,442,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-18-007942this filing2018-02-14acceptance time not in the bulk data set